ArticleTherapeutic advances in gastroenterology2025

Comparative efficacy of subcutaneous infliximab switching in remission and non-remission patients with inflammatory bowel disease after intravenous maintenance: 1-year outcome from a multicentre cohort study.

June Hwa Bae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.